Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: A prospective, pilot study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 7, 2013, Pages 795-800

  Argenta, P A ^a   Kassing, M ^a   Truskinovsky, A M ^a   Svendsen, C A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Park Nicollet Medical Center   (United States)

Author keywords

Bariatric surgery; endometrial cancer; endometrial hyperplasia; weight loss

Indexed keywords

ANTIESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CHEMOPROPHYLAXIS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MORBID OBESITY; PATHOLOGIST; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; UTERINE CERVIX CYTOLOGY; WEIGHT REDUCTION;

ADULT; ASYMPTOMATIC DISEASES; BIOPSY; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MIDDLE AGED; OBESITY, MORBID; PILOT PROJECTS; PREVALENCE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84877731335     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12100     Document Type: Article

References (21)

1. Schindler AE,. Progestogen deficiency and endometrial cancer risk. Maturitas 2009; 62: 334-7.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM,. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-50.
4. Centers for Disease Control and Prevention. Obesity trends among US adults between 1985 and 2008.
5. Linkov F, Edwards E, Balk J, Yurkovetsky Z, Stadterman B, Lokshin A, et al. Endometrial hyperplasia, endometrial cancer and prevention: Gaps in existing research of modifiable risk factors. Eur J Cancer 2008; 44: 1632-44.
6. Walker JL, Zuna RE,. Endometrial Hyperplasia, Estrogen therapy, and the prevention of endometrial cancer. In:, Disaia PJ, and, Creasman WT, editors. Clinical Gynecologic Oncology, 7th edn. Mosby Elsevier: Philadelphia, PA; 2007; pp. 125-46.
7. Mutter GL,. Diagnosis of premalignant endometrial disease. J Clin Pathol 2002; 55: 326-31.
8. Kurman RJ, Kaminski PF, Norris HJ,. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985; 56: 403-12.
9. Schirmer B,. Morbid Obesity. In:, Townsend CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery, 17th edn. Philadelphia, PA: Elsevier; 2004. pp. 357-99.
10. Teitelman M, Grotegut CA, Williams NN, Lewis JD,. The impact of bariatric surgery on menstrual patterns. Obes Surg 2006; 16: 1457-63.
11. Perugini RA, Malkani S,. Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of 'reversibility'. Curr Opin Endocrinol Diabetes Obes 2011; 18: 119-28.
12. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C,. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis 2011; 7: 561-8.
13. Gosman GG, Katcher HI, Legro RS,. Obesity and he role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006; 12: 585-601.
14. Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CFM, Bahamondes L,. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Aust N Z J Obstet Gynaecol 2008; 48: 207-13.
15. Smith RA, Cokkinides V, Brawley OW,. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009; 59: 27-41.
16. Fader AN, Nieves Arriba L, Frasure HE, von Gruenigen VE,. Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114: 121-7.
17. Havrilesky LJ, Maxwell GL, Myers ER,. Cost-effectiveness of annual screening strategies for endometrial cancer. Am J Obstet Gynecol 2009; 200: 640. e1-8.
18. Randall TC, Kurman RJ,. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under the age of 40. Obstet Gynecol 1997; 90: 434-40.
19. Rodriguez GC, Yaqub N, King ME,. A comparison of the Pipelle device and the Vabra aspirator as measured by endometrial denudation in hysterectomy specimens: the Pipelle device samples significantly less of the endometrial surface than the Vabra aspirator. Am J Obstet Gynecol 1993; 168: 55-9.
20. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ,. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995; 86: 38-42.
21. Leitao MM Jr, Kehoe S, Barakat RR, Alektiar K, Gattoc LP, Rabbitt C, et al. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 2009; 113: 105-8.